Company News: Page (1) of 1 - 08/06/18 Email this story to a friend. email article Print this page (Article printing at page facebook

Eiger BioPharmaceuticals Announces First Patient Enrolled in Phase 2 LIFT Study of Pegylated Interferon Lambda in Combination with Ritonavir-Boosted Lonafarnib at National Institutes of Health

  (August 06, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Business,HDV,Law,USA, Inc.,Medicine,Disease,Cancer,Surgery,Medication,Science,Lifestyle,Medical,Cancer,Business,Other,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved